← Baroda BNP Paribas Mutual Fund

Baroda BNP Paribas Innovation Fund Direct plan - Growth Option

Equity Data as of Sep 2026 Comparing Aug 2026 → Sep 2026
Share: WhatsApp X
Stocks Held
47
Sep 2026
Equity Holdings
₹812.27 Cr
Equity only, excl. debt & cash
AAUM
₹894.88 Cr
Jul-Sep 2026 · Direct + Regular
Top 5 Weight
21.0%
Diversified
Top 10 Weight
37.3%
Diversified
Changes
47
1 new · 1 exits
Top Sector
Pharmaceuticals & Biotechnology
14.6% of portfolio
Launch Date
14 Feb 2024
2 years old

AAUM (Average Assets Under Management) of ₹894.88 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.

📋 What Happened This Month Baroda BNP Paribas Innovation Fund Direct plan made 1 new addition and exited 1 stock this month. The biggest new buy was Manipal Payment and Identity Solutions Ltd (Financial Technology (Fintech)) at 1.93% weight. Symbiotec Pharmalab Limited was the biggest exit (Pharmaceuticals & Biotechnology), which was held at 0.03%. Among existing holdings, Acutaas Chemicals Ltd saw the biggest increase — now at 3.82% of the portfolio. Sagility Limited was trimmed the most, now at 1.34%. One 97 Communications Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 14.6%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Jul 2026 → Aug 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 13.8% 14.1% ▲ +0.3%
Financial Technology (Fintech) 8.2% 9.3% ▲ +1.1%
Chemicals & Petrochemicals 8.7% 8.5% ▼ -0.2%
Retailing 8.5% 8.2% ▼ -0.3%
Capital Markets 8.2% 8.2% ● +0.0%
Automobiles 6.8% 6.3% ▼ -0.5%
Electrical Equipment 4.9% 5.3% ▲ +0.4%
IT - Services 5.2% 4.7% ▼ -0.5%
Auto Components 3.6% 4.0% ▲ +0.4%
Industrial Products 4.7% 4.0% ▼ -0.7%
Aug 2026 → Sep 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 14.1% 14.6% ▲ +0.5%
Financial Technology (Fintech) 9.3% 10.3% ▲ +1.0%
Chemicals & Petrochemicals 8.5% 9.2% ▲ +0.7%
Retailing 8.2% 8.5% ▲ +0.3%
Capital Markets 8.2% 8.2% ● +0.1%
Automobiles 6.3% 6.2% ● -0.1%
Electrical Equipment 5.3% 5.1% ▼ -0.2%
Auto Components 4.0% 4.0% ● +0.0%
IT - Services 4.7% 3.9% ▼ -0.7%
Industrial Products 4.0% 3.7% ▼ -0.3%
🟢
Biggest New Buy
Manipal Payment and Identity Solutions Ltd
1.93% weight · Financial Technology (Fintech)
🔴
Biggest Exit
Symbiotec Pharmalab Limited
0.03% was held · Pharmaceuticals & Biotechnology
↑
Biggest Add
Acutaas Chemicals Ltd
+0.38% · now 3.82%
↓
Biggest Trim
Sagility Limited
-0.81% · now 1.34%
🤝 Other funds also bought this month
Manipal Payment and Identity Solutions Ltd 20 funds
Manipal Payment and Identity Solutions Ltd
Groww Banking & Financial Services Fund - Direct Plan - Growth
Groww Small Cap Fund-Direct-Growth
Groww Multicap Fund - Direct - Growth + more
👋 Other funds also exited
Symbiotec Pharmalab Limited 20 funds
Symbiotec Pharmalab Limited
WhiteOak Capital Multi Asset Allocation Fund Direct Plan Growth
Edelweiss Aggressive Hybrid Fund-Direct Plan-Growth Option
Baroda BNP Paribas Large & Mid Cap Fund + more

What Changed in the Portfolio This Month?

Comparing Aug 2026 → Sep 2026

Aug 2026 → Sep 2026
🟢 1 New Entry 🔴 1 Exit ↑ 22 Increased ↓ 23 Decreased
#StockSectorWeight (Sep 2026)
1
Manipal Payment and Identity Solutions Ltd
₹16.57 Cr
Financial Technology (Fintech) 1.93%
#StockSectorLast Weight (Aug 2026)
1
Symbiotec Pharmalab Limited
₹25.80 L
Pharmaceuticals & Biotechnology 0.03%
#StockSectorAug 2026Sep 2026Change
1
Acutaas Chemicals Ltd
₹32.79 Cr
Pharmaceuticals & Biotechnology 3.44% 3.82% +0.38%
2
Atul Limited
₹6.92 Cr
Chemicals & Petrochemicals 0.55% 0.81% +0.26%
3
Lenskart Solutions Limited
₹22.20 Cr
Retailing 2.34% 2.58% +0.24%
4
One 97 Communications Limited
₹45.31 Cr
Financial Technology (Fintech) 5.05% 5.27% +0.22%
5
Linde India Limited
₹34.95 Cr
Chemicals & Petrochemicals 3.85% 4.07% +0.22%
6
Aequs Limited
₹9.18 Cr
Aerospace & Defense 0.87% 1.07% +0.20%
7
Divi's Laboratories Limited
₹37.17 Cr
Pharmaceuticals & Biotechnology 4.13% 4.32% +0.19%
8
Fine Organic Industries Limited
₹7.38 Cr
Chemicals & Petrochemicals 0.67% 0.86% +0.19%
9
Eternal Limited
₹27.20 Cr
Retailing 3.04% 3.16% +0.12%
10
Multi Commodity Exchange of India Limited
₹26.73 Cr
Capital Markets 3.00% 3.11% +0.11%
#StockSectorAug 2026Sep 2026Change
1
Sagility Limited
₹11.50 Cr
IT - Services 2.15% 1.34% -0.81%
2
PB Fintech Limited
₹11.01 Cr
Financial Technology (Fintech) 2.02% 1.28% -0.74%
3
Max Financial Services Limited
₹12.36 Cr
Insurance 1.98% 1.44% -0.54%
4
Ujjivan Small Finance Bank Limited
₹4.86 Cr
Banks 1.08% 0.57% -0.51%
5
Pine Labs Limited
₹15.46 Cr
Financial Technology (Fintech) 2.23% 1.80% -0.43%
6
Polycab India Limited
₹16.61 Cr
Industrial Products 2.26% 1.93% -0.33%
7
GE Vernova T&D India Limited
₹13.23 Cr
Electrical Equipment 1.65% 1.54% -0.11%
8
Hitachi Energy India Limited
₹30.32 Cr
Electrical Equipment 3.64% 3.53% -0.11%
9
Mahindra & Mahindra Limited
₹18.59 Cr
Automobiles 2.25% 2.16% -0.09%
10
Fractal Analytics Ltd
₹9.99 Cr
IT - Software 1.25% 1.16% -0.09%

What Stocks Does This Fund Hold?

47 stocks — Sep 2026

# Stock Sector Cap Weight & Value
1
₹45.31 Cr
Financial Technology (Fintech)
5.27%
2
₹37.17 Cr
Pharmaceuticals & Biotechnology
4.32%
3
₹34.95 Cr
Chemicals & Petrochemicals
4.07%
4
₹32.79 Cr
Pharmaceuticals & Biotechnology
3.82%
5
₹30.32 Cr
Electrical Equipment
3.53%
6
₹29.68 Cr
Chemicals & Petrochemicals
3.45%
7
₹28.26 Cr
Auto Components
3.29%
8
₹28.13 Cr
Automobiles
3.27%
9
₹27.20 Cr
Retailing
3.16%
10
₹26.73 Cr
Capital Markets
3.11%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
→
🏦 Baroda BNP Paribas Mutual Fund — Portfolio & Holdings
See all funds managed by Baroda BNP Paribas Mutual Fund — conviction stocks, monthly entries & exits
→

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.